New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis

(MedPage Today) -- Studies were presented at the American College of Rheumatology (ACR) annual meeting on the safety and efficacy of two oral tyrosine kinase 2 (TYK2) inhibitors -- TAK-279, a selective TYK2 inhibitor in patients with active psoriatic...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news